Recursion Pharmaceuticals Inc (RXRX)
7.24
+0.25
(+3.58%)
USD |
NASDAQ |
Dec 24, 16:00
Recursion Pharmaceuticals Free Cash Flow: -335.64M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Revance Therapeutics Inc | -194.91M |
| Intuitive Surgical Inc | 586.00M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -59.22M |
| Cash from Investing (Quarterly) | -4.562M |
| Cash from Financing (Quarterly) | 16.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2257 |
| Free Cash Flow to Equity (Quarterly) | -61.49M |
| Free Cash Flow to Firm (Quarterly) | -63.79M |
| Free Cash Flow Yield | -18.87% |